Lidoject 1 Interactions
There are 549 drugs known to interact with Lidoject 1 (lidocaine), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 36 are major, 410 are moderate, and 103 are minor.
- View all 549 medications that may interact with Lidoject 1
- View Lidoject 1 alcohol/food interactions (1)
- View Lidoject 1 disease interactions (6)
Most frequently checked interactions
View interaction reports for Lidoject 1 (lidocaine) and the medicines listed below.
- acetaminophen
- acetaminophen / butalbital / caffeine
- acetylcysteine
- Adderall (amphetamine / dextroamphetamine)
- Afrin Original (oxymetazoline nasal)
- albuterol
- Allegra Allergy (fexofenadine)
- allopurinol
- Amaryl (glimepiride)
- amiodarone
- amitriptyline
- amlodipine
- ampicillin
- anastrozole
- Aranesp (darbepoetin alfa)
- baclofen
- Bactrim (sulfamethoxazole / trimethoprim)
- escitalopram
- gabapentin
- Gleevec (imatinib)
- LidoSite (epinephrine / lidocaine)
- Lyrica (pregabalin)
- magnesium oxide
- metformin
- metoclopramide
- morphine
- nitroglycerin
- Xylocaine HCl with Epinephrine (epinephrine / lidocaine)
- Xylocaine with Epinephrine (epinephrine / lidocaine)
- Xylocaine with Epinephrine Dental Cartridges (epinephrine / lidocaine)
Lidoject 1 alcohol/food interactions
There is 1 alcohol/food interaction with Lidoject 1 (lidocaine).
Lidoject 1 disease interactions
There are 6 disease interactions with Lidoject 1 (lidocaine) which include:
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- sinus/AV node dysfunction
- electrolyte imbalance
More about Lidoject 1 (lidocaine)
- Check interactions
- Compare alternatives
- Latest FDA alerts (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.